Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center
Clinical trials sponsored by Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center, explained in plain language.
-
Withdrawn study sought to boost RA remission with teamwork and tech
Disease control TerminatedThis study was designed to test a team-based approach to help Hispanic adults with rheumatoid arthritis (RA) better manage their disease. The plan included education, nurse support, and home symptom tracking to improve treatment adherence and increase remission rates. However, th…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New daily pill could simplify tough bone infection treatment
Disease control OngoingThis study tests a new antibiotic called omadacycline, taken once a day by mouth, against standard antibiotics for bone and joint infections. About 180 adults with these infections will be randomly assigned to receive either omadacycline or the usual care. The goal is to see if o…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC
-
Withdrawn study sought to curb obesity in babies of overweight moms
Prevention TerminatedThis study was designed to test whether carefully controlling the amount of breast milk or formula given to babies of overweight mothers could prevent them from becoming obese later in childhood. Researchers planned to enroll mother-infant pairs where the mother had a high BMI. H…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Prevention
Last updated Jun 15, 2026 19:08 UTC
-
Can a common arthritis drug ease MPS pain? new trial explores adalimumab for rare genetic disease
Symptom relief OngoingThis study tests whether adalimumab, a drug used for arthritis, can reduce pain and improve joint movement in people with MPS I, II, or VI. Fourteen children and adults will receive either adalimumab or a placebo for 16 weeks, then all may receive the drug for up to a year. The g…
Phase: PHASE1, PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Jun 16, 2026 12:53 UTC
-
Lack of sleep messes with key hormones in older adults, study finds
Knowledge-focused OngoingThis study looks at how not getting enough sleep changes stress and sex hormones in healthy older men and women who have gone through menopause. Researchers will measure cortisol and testosterone levels before and after four nights of limited sleep, and also check how sleep loss …
Phase: EARLY_PHASE1 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 17, 2026 07:26 UTC
-
Sleep apnea and male hormones: study pulled before it began
Knowledge-focused TerminatedThis study was designed to find out how obstructive sleep apnea (OSA) speeds up the natural drop in testosterone as men age. Researchers planned to test men aged 30 to 70 with moderate to severe OSA using a special hormone-blocking drug to measure how the brain, pituitary gland, …
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:04 UTC
-
Can a healthy lifestyle rewrite sperm DNA? new study investigates
Knowledge-focused OngoingThis study looks at how diet and exercise can change the chemical markers on sperm DNA (called the epigenome) in overweight, inactive Hispanic men. Researchers will compare sperm from healthy active men and obese inactive men, then put 80 obese men into groups: no change, diet on…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:17 UTC